74 reports

Cystic Fibrosis

  • Cystic Fibrosis
  • Italy
  • Indiana
  • Drug Approval
  • Prescription Drug Sales

Cystic Fibrosis

  • Cystic Fibrosis
  • Netherlands
  • Indiana
  • Drug Approval
  • Prescription Drug Sales

Project Details: - StrategyR - A Trademark of Global Industry Analysts, Inc. - Project Edition: 8 - Influencer Pool: 1249 - MarketGlass™ Platform - Our influencer driven interactive research platform draws from unique perspectives of participating executives from featured companies....

  • Cystic Fibrosis
  • Mobile Application
  • World

‘Non-cystic fibrosis bronchiectasis (NCFB) - Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Non-cystic fibrosis bronchiectasis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Non-cystic...

  • Cystic Fibrosis
  • Respiratory Disease
  • Spain
  • France
  • Japan
  • Germany
  • United States
  • Italy
  • United Kingdom
  • World

KEY FINDINGS The global cystic fibrosis therapeutics market is anticipated to grow at a rate of 10.04% during the estimated period of 2020-2028. A rise in incidences of cystic fibrosis across the globe, an increase in medications against cystic fibrosis, and a hike in R&D investments towards the development of drugs to...

  • Cystic Fibrosis
  • World
  • Europe

Cystic Fibrosis (CF) Therapeutics Market Report Overview Cystic Fibrosis (CF) Therapeutics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Cystic Fibrosis (CF) Therapeutics market types and applications. It is a focused study on Cystic...

  • Therapy
  • Cystic Fibrosis
  • World
  • Health Provider Density

The global cystic fibrosis therapeutics market grew at a CAGR of around 15% during 2014-2019. Cystic fibrosis (CF) is a rare and progressive genetic disorder that is characterized by an abnormal movement of sodium and chloride across the gastrointestinal and respiratory tracts. This disorder can cause the development...

  • Cystic Fibrosis
  • World
  • Health Expenditure

Cystic Fibrosis (CF) Therapeutics Market by Drug Class (Pancreatic Enzyme Supplements, Mucolytic, Bronchodilators, and CFTR Modulators) and Route of Administration (Oral and Inhaled): Global Opportunity Analysis and Industry Forecast, 2019-2026 The global cystic fibrosis therapeutics market was valued at $4,615.4...

  • Cystic Fibrosis
  • World
  • APAC
  • Europe

The ongoing clinical trial research report- “2019 Cystic Fibrosis Ongoing Clinical Trials Study” analyzes the current scenario of all active Cystic Fibrosis trials across the world. The report presents top level analysis of global Cystic Fibrosis clinical trials across countries, companies and universities. It is designed to provide clear...

  • Cystic Fibrosis
  • Clinical Trial
  • World
  • APAC

##. Pipeline Analysis of Cystic Fibrosis

  • Cystic Fibrosis
  • United States
  • World
  • Mortality Rate
  • Pharmaceutical Revenue

Cystic Fibrosis

  • Dermatological Condition
  • Eye Disease
  • Ophthalmology
  • Cystic Fibrosis
  • World
  • Surgical Procedures Performed
  • Drug Approval

KEY FINDINGS The global airway clearance system market is anticipated to record a CAGR of 4.39% over the projected period of 2019-2028. The factors boosting global market growth are the surging prevalence of cystic fibrosis and coronavirus disease, a rise in government initiatives, and growth opportunities in developing...

  • Respiratory Disease
  • Cystic Fibrosis
  • World
  • APAC

##. Pipeline Analysis of Cystic Fibrosis

  • Cystic Fibrosis
  • Anti-Infective
  • World
  • United States
  • Hamilton County

The Global Airway Clearance System Market size is expected to reach $774.7 Million by 2025, rising at a market growth of 4.62% CAGR during the forecast period. Airway clearance comprises of various types of treatment that help people suffering from diseases like cystic fibrosis maintain a healthy lifestyle. ACTs (Airway Clearance Techniques)...

  • Respiratory Disease
  • Respiratory Device
  • Cystic Fibrosis
  • Home Healthcare
  • World
  • Health Expenditure

Airway Clearance System Market by type (Positive Expiratory Pressure, High Frequency Chest Wall Oscillation, Oscillating PEP devices, Intrapulmonary Percussive Ventilators and Mechanical Cough Assist), Application (Emphysema, Cystic fibrosis, Neuromuscular Bronchiectasis and End-User (Hospital & Clinics, Ambulatory Surgical Centers,...

  • Respiratory Disease
  • Cystic Fibrosis
  • Healthcare
  • World
  • APAC
  • Europe
  • Health Expenditure

CYSTIC FIBROSIS

  • Respiratory Monitoring
  • Healthcare
  • Home Healthcare
  • Medical Device
  • Cystic Fibrosis
  • APAC
  • Europe
  • Middle East
  • Africa
  • Chronic Obstructive Pulmonary Disease Prevalence
  • Smoking Prevalence

“Non-cystic Fibrosis Bronchiectasis (NCFB) – Pipeline Insight, 2020,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Non-cystic Fibrosis Bronchiectasis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by...

  • Cystic Fibrosis
  • Respiratory Disease
  • United States
  • World

Overview "Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) - Pipeline Insight, 2020" report outlays comprehensive insights of present scenario and growth prospects across the mechanism of action. A detailed picture of the Cystic Fibrosis Transmembrane Conductance Regulators (CFTR) pipeline landscape is provided,...

  • Cystic Fibrosis
  • World
  • Health Expenditure

The global clinical trial report- “2019 Cystic Fibrosis Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Cystic Fibrosis. It presents in-depth analysis of Cystic Fibrosis clinical trials across markets and companies. The research work is for providing complete understanding into trends in Cystic Fibrosis. The...

  • Cystic Fibrosis
  • Clinical Trial
  • World

Global Carrier Screening Market to Reach $2.93 Billion by 2029 Key Questions Answered in this Report: • How the carrier screening market is expected to have an impact on the healthcare industry? • What was the total revenue generated by the global carrier screening market for autonomous in 2018...

  • Healthcare
  • Cystic Fibrosis
  • Genetic Disorder
  • Blood Disease
  • Laboratory
  • Neurological Disorder
  • World

In May 2013, Chrysalis Pharma filed a patent application (PCT/FR2013/##) entitled Tritoqualine for use in the treatment of cystic fibrosis".

  • Dermatological Condition
  • Pharmaceutical
  • Ophthalmology
  • Cystic Fibrosis
  • Ophthalmic Solution
  • Eye Disease
  • World
  • Surgical Procedures Performed
  • Pharmaceutical Registrations

KEY FINDINGS The cystic fibrosis therapeutics market of Europe is anticipated to register a CAGR of 10.10% over the projected period of 2020-2028. Europe has the largest market share in the global market in terms of revenue. A rise in the incidence of cystic fibrosis has given rise to the need for newer and advanced therapeutics...

  • Healthcare
  • Cystic Fibrosis
  • Europe
  • Poland
  • Russia
  • Health Expenditure

KEY FINDINGS The North America cystic fibrosis therapeutics market is estimated to register a CAGR of 10.07% over the projected period of 2020-2028. The market in North America is mainly driven by the presence of significant players in the biotechnology industry such as Vertex Pharmaceuticals Incorporated, Mylan N.V., and...

  • Cystic Fibrosis
  • Healthcare
  • North America
  • Health Expenditure

KEY FINDINGS The cystic fibrosis therapeutics market of Asia Pacific is estimated to record a CAGR of 9.58% during the projected period of 2020-2028.The rising research and development activities in terms of novel cystic fibrosis therapeutics are anticipated to create lucrative opportunities in the future. MARKET...

  • Cystic Fibrosis
  • APAC
  • Health Expenditure

In May 2013, Chrysalis Pharma filed a patent application (PCT/FR2013/##) entitled Tritoqualine for use in the treatment of cystic fibrosis".

  • Pharmaceutical
  • Cystic Fibrosis
  • World
  • Drug Approval
  • Pharmaceutical Registrations

the analyst has compiled a study on mucus clearance devices, which offers an analysis and forecast of the mucus clearance devices market in its publication titled Mucus Clearance Devices: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028. This report on mucus clearance devices market covers some of the vital facets...

  • Chronic Disease
  • Cystic Fibrosis
  • World
  • Asia
  • Africa

Overview “ Kalydeco - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Kalydeco in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Cystic Fibrosis
  • Clinical Trial
  • Hospital
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure
  • Use Of Prescription Drugs

Overview “Symdeko - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Symdeko in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Cystic Fibrosis
  • Clinical Trial
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • United States
  • Health Expenditure

Overview “ Trikafta - Drug Insight and Market Forecast - 2030” report outlays comprehensive insights of the product indicated for the treatment of its approved condition. A detailed picture of the Trikafta in Seven Major Markets, i.e., United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan,...

  • Clinical Trial
  • Cystic Fibrosis
  • Europe
  • Japan
  • World
  • Spain
  • France
  • Germany
  • Italy
  • United Kingdom
  • Health Expenditure

The Global Newborn Screening Market is poised to grow strong during the forecast period 2017 to 2027.. Some of the prominent trends that the market is witnessing include rising incidences of critical congenital heart defects (CCHD) and government support towards newborn child health. Depending on Test Type, the...

  • Healthcare
  • Cardiovascular Disease
  • Diagnostics
  • Endocrine Disease
  • Ambulatory Care
  • Cystic Fibrosis
  • Blood Disease
  • Respiratory Monitoring
  • In Vitro Diagnostic Reagent
  • Cardiology
  • Oxygen Device
  • Laboratory
  • Clinic
  • Nursing Home
  • World